May 20, 2019 article Open access Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease New England Journal of Medicine DOI: 10.1056/nejmoa1903076 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 22 stored of 1,677 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design 2026 Annals of the Rheumatic Diseases article Medicine Systemic Sclerosis and Related Diseases Open access 0 citations Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study 2026 The Lancet Rheumatology article Medicine Systemic Sclerosis and Related Diseases Open access 2 citations Extrarenal disease in ANCA-associated vasculitis: challenges and evolving therapeutic strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA 2026 Nephrology Dialysis Transplantation article Medicine Vasculitis and related conditions Open access 0 citations The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133) 2026 Annals of the Rheumatic Diseases article Medicine Systemic Sclerosis and Related Diseases Open access 5 citations A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score 2025 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 8 citations Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study 2025 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 7 citations Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti‐Fibrotic Treatment: Real‐World Data From the Dutch National Registry 2025 Respirology article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access 5 citations Fibrosis: cross-organ biology and pathways to development of innovative drugs 2025 Nature Reviews Drug Discovery review Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access 97 citations Quantitative 18F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis 2024 Arthritis Research & Therapy article Medicine Systemic Sclerosis and Related Diseases Open access 12 citations The role of vasculature and angiogenesis in respiratory diseases 2024 Angiogenesis article Biochemistry, Genetics and Molecular Biology Angiogenesis and VEGF in Cancer Open access 56 citations Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis 2023 RMD Open article Medicine Systemic Sclerosis and Related Diseases Open access 17 citations Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies 2023 Molecular Aspects of Medicine article Medicine Liver physiology and pathology 146 citations Interstitial Lung Disease 2023 Rheumatic Disease Clinics of North America article Medicine Systemic Sclerosis and Related Diseases Open access 11 citations S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im Erwachsenenalter 2023 Pneumologie article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access 56 citations Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region 2022 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 27 citations Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials 2022 The Lancet Rheumatology article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access 30 citations Gastrointestinal symptom severity and progression in systemic sclerosis 2022 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 19 citations New risk model is able to identify patients with a low risk of progression in systemic sclerosis 2021 RMD Open article Medicine Systemic Sclerosis and Related Diseases Open access 10 citations Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand 2020 Transfusion Clinique et Biologique article Business, Management and Accounting Blood donation and transfusion practices cited by 1 patent 52 citations Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide 2020 Arthritis Care & Research article Medicine Systemic Sclerosis and Related Diseases Open access 21 citations 1–20 of 22 Page 1 / 2 Next → References 0